AbbVie Inc.
ABBV
•Stock Analysis$182.31
+0.00 (+0.00%)• Live
AbbVie Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for AbbVie Inc.
Key Financial Metrics
for AbbVie Inc.
P/E Ratio
80.71
Revenue Growth
+3.71%
EPS Growth
-12.09%
Market Cap
$338.27B
Dividend Yield
+3.33%
Debt/Equity
49.22
ROIC
+17.93%
FCF Yield
+4.55%
View additional metrics
Valuation
P/B Ratio238.43
EV/Sales7.02
Financial Health
Current Ratio0.76
Return on Assets+9.90%
Analyst Recommendations
for AbbVie Inc.
39 analysts
Consensus: Buy
About
for AbbVie Inc.
Company Details
for AbbVie Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Michael CPA
Employees
55,000
Market Cap
322.03B
Exchange
New York Stock Exchange
IPO Date
January 2, 2013
Website
www.abbvie.comCIK
0001551152
ISIN
US00287Y1091
CUSIP
00287Y109
Country
US
Balance Sheet
for AbbVie Inc.
Cash Flow Statement
for AbbVie Inc.
Income Statement
for AbbVie Inc.
News
No news available at the moment.